Aino Health AB (OSTO:AINO) Current Deferred Revenue: kr0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:AINO Aino Health AB OSTO:AINO
31 GF Score
Price kr0.21
GF Value kr0.12
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Aino Health AB Current Deferred Revenue?

Aino Health AB OSTO:AINO 31 Current Deferred Revenue is kr0.00 Mil as of Jun. 2026. GuruFocus rates OSTO:AINO with a GF Score™ of 31/100 and a GF Value™ of kr0.12 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Aino Health AB's current deferred revenue for the quarter that ended in Jun. 2026 was kr0.00 Mil.

Aino Health AB Current Deferred Revenue Related Terms

Aino Health AB Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Aino Health AB's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aino Health AB Current Deferred Revenue Chart

Aino Health AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Aino Health AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OSTO:AINO
31GF Score
Aino Health AB OSTO:AINO
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of kr0.00 Mil mean?
Aino Health AB (OSTO:AINO) has a Current Deferred Revenue of kr0.00 Mil as of Jun. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Aino Health AB and its competitors.
Is Aino Health AB's Current Deferred Revenue too high?
Aino Health AB's current Current Deferred Revenue is kr0.00 Mil. Overall, Aino Health AB has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aino Health AB's Current Deferred Revenue compare to VEEV and BTSG?
Aino Health AB's Current Deferred Revenue of kr0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Healthcare Providers & Services company?
A good Current Deferred Revenue depends on the Healthcare Providers & Services industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Aino Health AB and its competitors. Aino Health AB's current Current Deferred Revenue is kr0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aino Health AB stock overvalued right now?
Based on GuruFocus' analysis, Aino Health AB (OSTO:AINO) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.12, compared to a current price of kr0.21 — trading 75% above its estimated fair value. The current Current Deferred Revenue is kr0.00 Mil. Aino Health AB's overall GF Score™ is 31/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Aino Health AB (OSTO:AINO), the current Current Deferred Revenue is kr0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aino Health AB (OSTO:AINO) Overvalued in 2026?

Based on GuruFocus' analysis, Aino Health AB stock appears to be overvalued. The current stock price of kr0.21 is trading 75% above its estimated GF Value™ of kr0.12. GuruFocus considers Aino Health AB to be Significantly Overvalued.

Key valuation signals for OSTO:AINO:

  • Current Deferred Revenue: kr0.00 Mil
  • GF Value™: kr0.12 vs. price of kr0.21 (75% above fair value)
  • GF Score™: 31/100 with 5 warning signs

No single metric tells the full story. See the OSTO:AINO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aino Health AB Business Description

Other Exchanges 50V:Germany
Address c/o Hermelin & Friends, Kungsgatan 32, Stockholm, SWE, 111 35
Aino Health AB provides corporate health management solutions. The company has developed a complete system of IT-based services with a focus on improving corporate health and reducing sickness absence levels in private and public organizations. Its solution consists of HealthManager, HealthDesk, and Consulting services. Company SaaS platform combines advance data analytics, research-based insights, and AI to empower leaders to unlock the full potential of their teams and to foster a healthier, more sustainable work environment.
31GF Score

Get the complete analysis for OSTO:AINO

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.21
Price
kr0.12
GF Value